## COR: Cencora, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -7.8% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($322.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Federated Hermes Inc. Increases Stock Holdings in Cencora, Inc. $COR**
- Source: MarketBeat | 20251207T121247 | Bullish | Relevance: 99%
- Federated Hermes Inc. significantly increased its stake in Cencora, Inc. (NYSE:COR) by 24.1% in the second quarter, acquiring an additional 133,907 shares to own a total of 688,656 shares valued at approximately $206.5 million. Cencora recently reported better-than-expected quarterly earnings of $3.84 EPS and revenue of $83.73 billion, while also raising its quarterly dividend to $0.60 per share. Despite some insider selling, institutional investors own a substantial 97.52% of the company, and analysts generally maintain a "Moderate Buy" rating with an average price target of $371.09.

**2. Cencora, Inc. $COR Shares Sold by California Public Employees Retirement System**
- Source: MarketBeat | 20251208T094640 | Neutral | Relevance: 99%
- Cencora, Inc. (NYSE:COR) saw its shares sold by the California Public Employees Retirement System, which trimmed its stake by 11% during the second quarter. Corporate insiders have also been net sellers. Despite this, analysts are generally positive, with several firms raising price targets, resulting in a "Moderate Buy" consensus rating.

**3. Burgundy Asset Management Ltd. Sells 157,024 Shares of Cencora, Inc. $COR**
- Source: MarketBeat | 20251207T100603 | Somewhat-Bullish | Relevance: 98%
-  Burgundy Asset Management Ltd. reduced its stake in Cencora, Inc. (NYSE:COR) by 20.5% in Q2, selling 157,024 shares and now owning 610,478 shares valued at $183 million. Other hedge funds, including Baader Bank Aktiengesellschaft and Acadian Asset Management LLC, significantly increased their holdings in Cencora. Insiders at Cencora, including CEO Robert P. Mauch and Chairman Steven H. Collis, have sold a total of 46,640 shares valued at over $14 million in the last three months.

**4. Lombard Odier Asset Management USA Corp Invests $3.16 Million in Cencora, Inc. $COR**
- Source: MarketBeat | 20251209T134716 | Somewhat-Bullish | Relevance: 98%
-  Lombard Odier Asset Management USA Corp recently acquired a new stake in Cencora, Inc. (NYSE:COR) by purchasing 10,534 shares worth approximately $3.16 million during the second quarter. This investment highlights institutional interest in Cencora, with hedge funds and institutional investors collectively owning a significant portion of the company's stock. The article also details recent insider selling activities, Cencora's financial performance, dividend increase, and analyst ratings.

**5. JPMorgan raises Cencora (COR) price target after financial model update**
- Source: MSN | 20251210T000920 | Bullish | Relevance: 98%
- JPMorgan has raised its price target for Cencora (COR) following an update to its financial model. The specific details of the financial model update and the new price target are not provided in this snippet.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $400 | $0 | 0% |
| 2025-11-11 | JP Morgan | $417 | $344 | +21% |
| 2025-11-11 | Wells Fargo | $405 | $354 | +14% |
| 2025-11-10 | TD Cowen | $400 | $350 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |
| 2025-11-11 | JP Morgan | main | Overweight |
| 2025-11-11 | Wells Fargo | main | Overweight |
| 2025-11-10 | TD Cowen | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+4.1%)
- Blackrock Inc.: 10.2% (+5.7%)
- JPMORGAN CHASE & CO: 4.8% (+139.5%)
- State Street Corpora: 4.7% (+9.3%)
- Price (T.Rowe) Assoc: 4.0% (-0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +17%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Quality metrics strong (ROE 124%). Balance sheet: $2.9B free cash flow. Analyst sentiment positive (3 raises, avg +17%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $65.4B |
| Beta | 0.63 |
| 52W Range | $223.92 - $377.54 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 17.3 |
| Current P/E | 19.1 |
| YoY Growth | 10.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -9.1% to -7.8% (+1.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 11.8pp (needs >4.0% for momentum thesis). AM_20 at -5.7% indicates price below own 20MA trend. Underperforming sector by 3.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). MACD histogram bearish (-4.94), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -7.75% (CS: 4) | Weak |
| RSI_14 | 38.7 | Neutral |
| MACD Histogram | -4.94 | Bearish |
| vs SMA20 | 0.943x | Below |
| vs SMA50 | 0.992x | Below |
| vs SMA200 | 1.126x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $337.29
- **Stop Loss:** $322.39 (4.4% risk)
- **Target:** $352.19 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $6,745.80
- **Portfolio %:** 6.75%
- **Risk Dollars:** $300.00
- **Risk Per Trade:** 0.30%
- **Modifiers:** L1 100% | L2 25% | Combined 0.30x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TOXIC (Zone G) | 0.25x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-04 (Est: $4.07)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.79 | $3.84 | +1.4% |
| 2025Q2 | $3.84 | $4.00 | +4.2% |
| 2025Q1 | $4.10 | $4.42 | +7.9% |
| 2024Q4 | $3.52 | $3.73 | +6.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*